tiprankstipranks
RAPT Therapeutics (RAPT)
NASDAQ:RAPT
US Market

RAPT Therapeutics (RAPT) Income Statement

Compare
360 Followers

RAPT Therapeutics Income Statement

Last quarter (Q3 2024), RAPT Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, RAPT Therapeutics's net income was $-18.43M. See RAPT Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 0.00$ 1.53M$ 3.81M$ 5.04M$ 0.00
Gross Profit
$ -3.55M$ -1.28M$ 2.82M$ 5.04M$ -1.33M
Operating Expenses
$ 127.06M$ 87.32M$ 73.02M$ 58.26M$ 43.63M
Depreciation and Amortization
$ 1.22M$ 2.81M$ 996.00K$ 1.12M$ 1.33M
EBITDA
$ -125.85M$ -84.75M$ -68.21M$ -52.09M$ -42.30M
Operating Income
$ -127.06M$ -85.80M$ -69.21M$ -53.21M$ -43.63M
Other Income/Expenses
$ 10.26M$ 1.96M$ 5.00K$ 1.31M$ 1.29M
Pretax Income
$ -116.80M$ -83.84M$ -69.20M$ -51.90M$ -42.34M
Net Income
$ -116.80M$ -81.88M$ -68.21M$ -52.89M$ -43.00M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -3.05$ -2.52$ -2.49$ -2.19$ -1.97
Diluted EPS
$ -3.05$ -2.52$ -2.49$ -2.19$ -1.97
Weighted Average Shares Outstanding
38.34M 32.54M 27.39M 24.13M 21.83M
Weighted Average Shares Outstanding (Diluted)
38.34M 32.54M 27.39M 24.13M 21.83M
Currency in USD

RAPT Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis